Workup and Documentation of Findings

Management Decisions

Effect of Age on Disease Incidence

Diseases and Conditions Not Limited to the Vulva

• Acneiform Eruptions

• Alopecia

• Atopic, Contact and Irritant Dermatitis

• Chronic Venous Insufficiency and Other Vascular Problems

• Dyspigmentation

• Hydradenitis Suppurativa

• Keloids

• Skin Cancers and Other Photodamage

• Striae

Vulvar Pathology

• Viral Infections

• Bacterial and Fungal Infections

• Vulvar Intraepithelia Neoplasia

Special Issues in Pregnancy

Summary

CME Post-Test and Program Evaluation

Anita L. Nelson, MD (Co-Chair)
Professor, Department of Obstetrics and Gynecology
David Geffen School of Medicine at UCLA
Los Angeles
Clinical Grants: Berlex Laboratories, National Institutes of Health, National Center for Medical Rehabilitation Research, Organon, Ortho-McNeil Pharmaceutical, Pharmacia Corporation. Speaker's Bureau: Berlex, Eli Lilly & Company, 3M Pharmaceuticals, Ortho-McNeil, Organon, Pfizer Inc., Pharmacia, Solvay Pharmaceuticals, Inc. and Wyeth. She discusses the investigational use of imiquimod for treating molluscum contagiosum and BCC and discusses the investigational use of low-dose tricyclic antidepressants as a treatment for pruritis.

Stephen K. Tyring, MD, PhD (Co-Chair)
Professor, Department of Microbiology & Immunology, Dermatology & Internal Medicine
University of Texas Medical Branch
Houston
Clinical Grants and Consultant to 3M. He discusses the investigational use of imiquimod for treating non-genital warts, molluscum contagiosum, BCC, AK, Paget's disease, and dysplasia and the investigational use of low-dose tricyclic antidepressants as a treatment for pruritis.

Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
Department of Dermatology & Cutaneous Surgery
University of Miami School of Medicine
Clinical Grants and Consultant to 3M. He discusses the investigational use of imiquimod 5% cream and interferon for treating keloids and basal cell carcinoma (BCC).

Michelle L. Geller, MD
Fellow in Women's Health
Internal Medicine
Department of OB/GYN
Harbor-UCLA Medical Center
Torrance, California
Nothing to disclose.

Richard Allen Johnson, MD
Instructor in Dermatology
Harvard Medical School
Clinical Associate in Dermatology
Massachusetts General Hospital
Boston
Speaker's Bureau: 3M Pharmaceuticals. He discusses the investigational use of imiquimod for treating actinic keratosis (AK), squamous cell carcinoma (SCC) and BCC.

Sherrill Jantzi Rudy, MSN, RN, CPNP
Pediatric Nurse Practitioner
Department of Dermatology
Children's Hospital of Dermatology
Children's Hospital of Pittsburgh
University of Pittsburgh Medical Center
She discusses the investigational use of low-dose tricyclic antidepressants as a treatment for pruritis.

Health care providers involved in the primary care of female patients, including obstetrician/gynecologists, nurse practitioners, and other health care providers.

Many women in the United States do not see a dermatologist regularly, but rely on their primary care clinicians for first-line management of skin problems. In fact, the primary care clinician—including the obstetrician/gynecologist, who often is the only physician a woman may see—should expect to include the skin as an organ system in any examination. Some may choose to treat some conditions and refer patients with more complex problems to dermatologists. It is important that clinicians seeing women for primary care remain up-to-date on the dermatologic conditions and diseases most likely to be encountered in the primary care or ob.gyn. office. Clinicians must be able to recognize lesions that require referral to a dermatology specialist and manage skin conditions and diseases that are appropriately diagnosed and treated in the primary care setting.

By reading and studying this supplement, participants should be able to:

• Explain the importance of incorporating examination of the skin and documentation of lesions into routine practice.

• Recognize and describe common skin lesions, such as macule, papule and pustule.

• List and describe the most common skin conditions in female patients most likely to be encountered in an ob. gyn. or primary care practice, whether located in the vulvar region or elsewhere on the body.

• Name and describe both older and newer agents that are commonly used in dermatology practice that seem to be underutilized in primary care settings.

• Identify common vulvar lesions and discuss current advances in primary care settings.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Excerpta Medica, Inc., and Ob.Gyn. News/Family Practice News. Excerpta Medica is accredited by the ACCME to provide continuing medical education for physicians.

Term of approval: April 2003 – April 2005.

Excerpta Medica designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.

This continuing nursing education activity for 1.75 contact hours is provided by Mosby Continuing Education and Training, which is accredited as a provider of continuing education in nursing by the American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA).

Anita L. Nelson, MD
Stephen K. Tyring, MD, PhD
Sylvia H. Reitman
Steven A. Weinman, RN
Margaret Camp, RN

Copyright © 2003 by International Medical News Group